Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Overview
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $51.6M
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) General Information
Description
Neoleukin Therapeutics was a biopharmaceutical company that generated immunotherapies using de novo protein design technology. The firm used computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Discovery Tools (Healthcare)
Biotechnology
Acquirer
Primary Office
- 401 Terry Avenue North
- Seattle, WA 98109
- United States
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 08-Aug-2019 | $51.6M | 00000 | 0000 | Completed | Generating Revenue/Not Profitable |
| 1. Early Stage VC | 08-Feb-2019 | 00000 | 00000 | Completed | Generating Revenue/Not Profitable |
Neoleukin Therapeutics (Acquired by Aquinox Pharmaceuticals) Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| WRF Capital | Venture Capital | Minority | 000 0000 | 000000 0 |